Prospective, single arm trial to assess the effects of renal denervation on day-by-day blood pressure measurements and time in blood pressure target range, as well as establish a multivariate prediction model for blood pressure reduction after renal denervation.
Confirmed arterial hypertension with systolic or diastolic blood pressure >140/90 mmHg in standardized office blood pressure measurement
Treatment with 3 to ≤5 antihypertensive drug classes
Age >18 years
Written informed consent
Age ≤ 18 years
anatomy unsuitable for renal denervation (i.e. renal artery stenosis, single functioning kidney)
pregnancy
patients under legal supervision or guardianship
Heart Center Leipzig - University Hospital
Lead sponsor
Helios Health Institute GmbH
Collaborator